|
1138427-50MG |
50MG |
|
Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one]) |
|
1138427-50MG |
50MG |
|
Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one]) |
|
1283426-25MG |
25MG |
|
FOSINOPRIL RELATED COMPOUND B 福辛普利相关化合物B |
|
1283426-25MG |
25MG |
|
FOSINOPRIL RELATED COMPOUND B 福辛普利相关化合物B |
|
1344746-40MG |
40MG |
|
Iopamidol Related Compound C |
|
1347653-15MG |
15MG |
|
Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate) Irinotecan Related Compound D United States Pharmacopeia (USP) Reference Standard |
|
1375070-15MG |
15MG |
|
Mangafodipir Related Compound A United States Pharmacopeia (USP) Reference Standard |
|
1375070-15MG |
15MG |
|
Mangafodipir Related Compound A United States Pharmacopeia (USP) Reference Standard |
|
1379445-30MG |
30MG |
|
Meloxicam Related Compound D |
|
1379445-30MG |
30MG |
|
Meloxicam Related Compound D |
|
1584014-25MG |
25MG |
|
Pyrantel Related Compound A |
|
1609831-25MG |
25MG |
|
Saquinavir Related Compound A |
|
1609831-25MG |
25MG |
|
Saquinavir Related Compound A |
| 100-44-7 |
1062019-600MG |
600MG |
|
Benzyl Chloride (3 x 200 mg) ((Chloromethyl)benzene) |
| 100-44-7 |
1062019-600MG |
600MG |
|
Benzyl Chloride (3 x 200 mg) ((Chloromethyl)benzene) |
| 10034-96-5 |
1375149-1G |
1G |
|
Manganese sulfate United States Pharmacopeia (USP) Reference Standard 硫酸锰 |
| 10034-96-5 |
1375149-1G |
1G |
|
Manganese sulfate United States Pharmacopeia (USP) Reference Standard 硫酸锰 |
| 10034-99-8 |
1374361-1G |
1G |
|
Magnesium sulfate 硫酸镁 |
| 10034-99-8 |
1374361-1G |
1G |
|
Magnesium sulfate 硫酸镁 |
| 100986-89-8 |
1362125-35MG |
35MG |
|
Levofloxacin Related Compound B 左旋氧氟沙星羧酸 |
| 100986-89-8 |
1362125-35MG |
35MG |
|
Levofloxacin Related Compound B 左旋氧氟沙星羧酸 |
| 100986-89-8 |
1362125-35MG |
35MG |
|
Levofloxacin Related Compound B 左旋氧氟沙星羧酸 |
| 10102-17-7 |
1615107-1G |
1G |
|
Sodium thiosulfate 硫代硫酸钠 |
| 10102-17-7 |
1615107-1G |
1G |
|
Sodium thiosulfate 硫代硫酸钠 |
| 1018676-02-2 |
1013523-20MG |
20MG |
|
Almotriptan Related Compound A |
| 102625-64-9 |
1494910-25MG |
25MG |
|
Pantoprazole Related Compound B |
| 102625-64-9 |
1494910-25MG |
25MG |
|
Pantoprazole Related Compound B |
| 102625-64-9 |
1494910-25MG |
25MG |
|
Pantoprazole Related Compound B |
| 103628-48-4 |
1642201-200MG |
200MG |
|
Sumatriptan succinate |
| 103733-49-9 |
1593412-50MG |
50MG |
|
Quinapril Related Compound A |
| 103733-49-9 |
1593412-50MG |
50MG |
|
Quinapril Related Compound A |
| 103733-51-3 |
1445619-20MG |
20MG |
|
Moexipril Related Compound B |
| 103733-51-3 |
1445619-20MG |
20MG |
|
Moexipril Related Compound B |
| 104872-06-2 |
1478811-25MG |
25MG |
|
Orlistat Related Compound A |
| 104872-06-2 |
1478811-25MG |
25MG |
|
Orlistat Related Compound A |
| 1072902-75-0 |
1478855-10MG |
10MG |
|
Orlistat Related Compound E |
| 1072902-75-0 |
1478855-10MG |
10MG |
|
Orlistat Related Compound E |
| 109-01-3 |
1154015-50MG |
50MG |
|
Cyclizine Related Compound A 1-甲基哌嗪 |
| 109-99-9 |
1601770-3X1.2ML |
3x1.2ml |
|
Residual Solvent Class 2 - Tetrahydrofuran 四氢呋喃 溶液 |
| 109-99-9 |
1601770-3X1.2ML |
3X1.2ML |
|
Residual Solvent Class 2 - Tetrahydrofuran 四氢呋喃 溶液 |
| 109010-60-8 |
1048674-15MG |
15MG |
|
Benazepril Related Compound F (S)-3-氨基-四氢-2-氧-1-苯并氮杂卓-1-乙酸叔丁酯 |
| 110-54-3 |
1601601-3X1.2ML |
3X1.2ML |
|
Residual Solvent Class 2 - Hexane 己烷 溶液 |
| 110-82-7 |
1601408-3X1.2ML |
3X1.2ML |
|
Residual Solvent Class 2 - Cyclohexane 环己烷 溶液 |
| 1122-58-3 |
1707894-50MG |
50MG |
|
Valacyclovir Related Compound G 4-(二甲氨基)吡啶 |
| 1148113-53-4 |
1041915-10MG |
10MG |
|
Aprepitant Related Compound A |
| 1148113-53-4 |
1041915-10MG |
10MG |
|
Aprepitant Related Compound A |
| 1159977-56-6 |
1724420-10MG |
10MG |
|
Ziprasidone Related Compound B |
| 1159977-56-6 |
1724420-10MG |
10MG |
|
Ziprasidone Related Compound B |
| 116169-18-7 |
1354218-15MG |
15MG |
|
Isradipine Related Compound A |
| 1166228-30-3 |
1071224-10MG |
10MG |
|
Bicalutamide Related Compound B |
| 1169702-90-2 |
1238228-20MG |
20MG |
|
Eprosartan Related Compound A |
| 1169702-90-2 |
1238228-20MG |
20MG |
|
Eprosartan Related Compound A |
| 119386-76-4 |
1667472-25MG |
25MG |
|
1-[2,4-Dichloro-β-[(5-bromo-2-chloro-3-thenyl)oxy]phenethyl]imidazole hydrochloride |
| 121-66-4 |
1463971-25MG |
25MG |
|
Nitazoxanide Related Compound A 2-氨基-5-硝基噻唑 |
| 1263278-77-8 |
1673533-20MG |
20MG |
|
Trazodone Related Compound C |
| 1263278-80-3 |
1673544-20MG |
20MG |
|
Trazodone Related Compound D |
| 129083-44-9 |
1269254-25MG |
25MG |
|
Famotidine Related Compound E |
| 129722-25-4 |
1042690-25MG |
25MG |
|
Aripiprazole Related Compound G |
| 1303996-68-0 |
1724441-10MG |
10MG |
|
Ziprasidone Related Compound C |
| 1303996-68-0 |
1724441-10MG |
10MG |
|
Ziprasidone Related Compound C |
| 131-48-6 |
1612619-200MG |
200MG |
|
N-Acetylneuraminic acid N -乙酰神经氨酸 |
| 1314-13-2 |
1724747-200MG |
200MG |
|
Zinc oxide 氧化锌 |
| 1314-13-2 |
1724747-200MG |
200MG |
|
Zinc oxide 氧化锌 |
| 1314-13-2 |
1724747-200MG |
200MG |
|
Zinc oxide 氧化锌 |
| 1314-13-2 |
1724747-200MG |
200MG |
|
Zinc oxide 氧化锌 |
| 1314-13-2 |
1724747-200MG |
200MG |
|
Zinc oxide 氧化锌 |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 1314-13-2 |
1724747-2G |
2G |
|
Zinc Oxide (200 mg) Zinc oxide United States Pharmacopeia (USP) Reference Standard |
| 131926-99-3 |
1356927-25MG |
25MG |
|
Lansoprazole Related Compound A |
| 1332724-03-4 |
1134255-25MG |
25MG |
|
Citalopram Related Compound B |
| 134-31-6 |
1490103-200MG |
200MG |
|
Oxyquinoline sulfate 8-羟基喹啉 半硫酸盐 |
| 13463-67-7 |
1667585-2G |
2G |
|
Titanium dioxide 二氧化钛 |
| 13463-67-7 |
1667585-2G |
2G |
|
Titanium dioxide 二氧化钛 |
| 136434-34-9 |
1229817-100MG |
100MG |
|
Duloxetine hydrochloride 度洛西汀 盐酸盐 |
| 136434-34-9 |
1229817-100MG |
100MG |
|
Duloxetine hydrochloride 度洛西汀 盐酸盐 |
| 13755-38-9 |
1614501-500MG |
500MG |
|
Sodium nitroprusside 硝普钠 |
| 138402-11-6 |
1347700-200MG |
200MG |
|
Irbesartan |
| 138564-59-7 |
1478312-15MG |
15MG |
|
Olanzapine Related Compound A |
| 139122-19-3 |
1605216-50MG |
50MG |
|
Ropinirole Related Compound A |
| 139264-69-0 |
1727031-20MG |
20MG |
|
Zolmitriptan Related Compound B |
| 139264-69-0 |
1727031-20MG |
20MG |
|
Zolmitriptan Related Compound B |
| 141-78-6 |
1265402-3X1.2ML |
3X1.2ML |
|
Ethyl acetate 乙酸乙酯 |
| 141625-93-6 |
1228530-125MG |
125MG |
|
Dronedarone hydrochloride |
| 144689-63-4 |
1478367 |
100mg |
|
Olmesartan Medoxomil (100 mg) 奥美沙坦酯 |
| 144689-63-4 |
1478367 |
100mg |
|
Olmesartan Medoxomil (100 mg) 奥美沙坦酯 |
| 144689-63-4 |
1478367-100MG |
100MG |
|
Olmesartan medoxomil |
| 144689-63-4 |
1478367-100MG |
100MG |
|
Olmesartan medoxomil |
| 14639-25-9 |
1133638-100MG |
100MG |
|
Chromium picolinate United States Pharmacopeia (USP) Reference Standard |
| 14639-25-9 |
1133638-100MG |
100MG |
|
Chromium picolinate United States Pharmacopeia (USP) Reference Standard |
| 147-85-3 |
1568506-200MG |
200MG |
|
?-Proline ?-脯氨酸 |
| 152305-23-2 |
1727086-25MG |
25MG |
|
Zolmitriptan Related Compound G (S)-4-(4-氨基苄基)-1,3-唑烷-2-酮 |
| 152305-23-2 |
1727086-25MG |
25MG |
|
Zolmitriptan Related Compound G (S)-4-(4-氨基苄基)-1,3-唑烷-2-酮 |
| 152305-23-2 |
1727086-25MG |
25MG |
|
Zolmitriptan Related Compound G (S)-4-(4-氨基苄基)-1,3-唑烷-2-酮 |
| 152305-23-2 |
1727086-25MG |
25MG |
|
Zolmitriptan Related Compound G (S)-4-(4-氨基苄基)-1,3-唑烷-2-酮 |
| 15362-40-0 |
1188811-25MG |
25MG |
|
Diclofenac related compound A N -（2,6-二氯苯基）-2-吲哚酮 |
| 154127-19-2 |
1076374-50MG |
50MG |
|
Brinzolamide Related Compound A |
| 154127-19-2 |
1076374-50MG |
50MG |
|
Brinzolamide Related Compound A |
| 154361-50-9 |
1090706-200MG |
200MG |
|
Capecitabine 卡培他滨 |
| 162537-11-3 |
1044356-25MG |
25MG |
|
Atazanavir Related Compound A |
| 1642559-71-4 |
1031547-50MG |
50MG |
|
Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) Amoxicillin Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 1642559-71-4 |
1031547-50MG |
50MG |
|
Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) Amoxicillin Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 168167-42-8 |
1598075-15MG |
15MG |
|
Rabeprazole Related Compound F |
| 168828-84-0 |
1367570-20MG |
20MG |
|
Linezolid Related Compound A 利奈唑胺相关化合物A |
| 168828-84-0 |
1367570-20MG |
20MG |
|
Linezolid Related Compound A 利奈唑胺相关化合物A |
| 168828-84-0 |
1367570-20MG |
20MG |
|
Linezolid Related Compound A 利奈唑胺相关化合物A |
| 168828-90-8 |
1367592-20MG |
20MG |
|
Linezolid Related Compound C |
| 168828-90-8 |
1367592-20MG |
20MG |
|
Linezolid Related Compound C |
| 168828-90-8 |
1367592-20MG |
20MG |
|
Linezolid Related Compound C |
| 1744-22-5 |
1604337-200MG |
200MG |
|
Riluzole 利鲁唑 |
| 174649-09-3 |
1367606-20MG |
20MG |
|
Linezolid Related Compound D |
| 174649-09-3 |
1367606-20MG |
20MG |
|
Linezolid Related Compound D |
| 174649-09-3 |
1367606-20MG |
20MG |
|
Linezolid Related Compound D |
| 174649-09-3 |
1367606-20MG |
20MG |
|
Linezolid Related Compound D |
| 174649-09-3 |
1367606-20MG |
20MG |
|
Linezolid Related Compound D |
| 177472-30-9 |
1362136-25MG |
25MG |
|
Levofloxacin Related Compound C |
| 177472-30-9 |
1362136-25MG |
25MG |
|
Levofloxacin Related Compound C |
| 177472-30-9 |
1362136-25MG |
25MG |
|
Levofloxacin Related Compound C |
| 188112-75-6 |
1031570-15MG |
15MG |
|
Amoxicillin Related Compound G (15 mg) ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) Amoxicillin Related Compound G United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
1727053-20MG |
20MG |
|
Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 192725-17-0 |
1370101-350MG |
350MG |
|
Lopinavir 洛匹那韦 |
| 19685-09-7 |
1347610-10MG |
10MG |
|
Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) Irinotecan Related Compound A United States Pharmacopeia (USP) Reference Standard |
| 21593-77-1 |
1013057-25MG |
25MG |
|
S-Allyl-L-cysteine S-烯丙基-L-半胱氨酸 |
| 219861-53-7 |
1134142-10MG |
10MG |
|
R-Citalopram oxalate |
| 22204-53-1 |
1457301-200MG |
200MG |
|
Naproxen 萘普生 |
| 22720-75-8 |
1724689-50MG |
50MG |
|
Zileuton Related Compound C 2-乙酰基苯并噻吩 |
| 22818-40-2 |
1031591-15MG |
15MG |
|
Amoxicillin Related Compound I (25 mg) ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid) |
| 22818-40-2 |
1031591-15MG |
15MG |
|
Amoxicillin Related Compound I (25 mg) ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid) |
| 22818-40-2 |
1031591-25MG |
25MG |
|
Amoxicillin Related Compound I ?-对羟基苯甘氨酸 |
| 22818-40-2 |
1031591-25MG |
25MG |
|
Amoxicillin Related Compound I ?-对羟基苯甘氨酸 |
| 24155-42-8 |
1231830-15MG |
15MG |
|
Econazole Related Compound A |
| 24683-26-9 |
1379412-25MG |
25MG |
|
Meloxicam Related Compound A 4-羟基-2-甲基-2H-1,2-苯并噻嗪-3-甲酸乙酯 1,1-二氧化物 |
| 26675-76-3 |
1448978-15MG |
15MG |
|
Mycophenolate Mofetil Related Compound B |
| 26675-76-3 |
1448978-15MG |
15MG |
|
Mycophenolate Mofetil Related Compound B |
| 27387-31-1 |
1478618-30MG |
30MG |
|
Ondansetron Related Compound C |
| 27503-81-7 |
1530809-200MG |
200MG |
|
Ensulizole 2-苯基-5-苯并咪唑磺酸 |
| 27511-79-1 |
1013024-25MG |
25MG |
|
Allopurinol Related Compound A 3-氨基-4-吡唑甲酰胺 半硫酸盐 |
| 30165-96-9 |
1667348-20MG |
20MG |
|
Timolol Related Compound F 3-氯-4-吗啉基-1,2,5-噻二唑 |
| 30165-96-9 |
1667348-20MG |
20MG |
|
Timolol Related Compound F 3-氯-4-吗啉基-1,2,5-噻二唑 |
| 30165-97-0 |
1667369-20MG |
20MG |
|
Timolol Related Compound D |
| 30165-97-0 |
1667369-20MG |
20MG |
|
Timolol Related Compound D |
| 303-26-4 |
1333058-25MG |
25MG |
|
Hydroxyzine Related Compound A 1-(4-氯二苯甲基)哌嗪 |
| 328385-86-0 |
1368610-15MG |
15MG |
|
Lisinopril Related Compound A (250 mg) ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-alpha]pyrazin-2(1H)-yl}-4-phenylbutanoic acid) Lisinopril Related Compound A United States Pharmacopeia (USP) Reference Standard |
| 328385-86-0 |
1368610-250MG |
250MG |
|
Lisinopril Related Compound A |
| 3533-97-9 |
1511021-15MG |
15MG |
|
Perphenazine Related Compound B |
| 3533-97-9 |
1511021-15MG |
15MG |
|
Perphenazine Related Compound B |
| 366789-02-8 |
1604530-200MG |
200MG |
|
Rivaroxaban |
| 366789-02-8 |
1604530-200MG |
200MG |
|
Rivaroxaban |
| 366789-02-8 |
1604530-200MG |
200MG |
|
Rivaroxaban |
| 37052-78-1 |
1478480-15MG |
15MG |
|
Omeprazole Related Compound B 5-甲氧基-2-巯基苯并咪唑 |
| 37052-78-1 |
1478480-15MG |
15MG |
|
Omeprazole Related Compound B 5-甲氧基-2-巯基苯并咪唑 |
| 39236-46-9 |
1336806-200MG |
200MG |
|
Imidurea 咪唑烷基脲 |
| 4205-91-8 |
1140407-200MG |
200MG |
|
Clonidine hydrochloride 可乐定 盐酸盐 |
| 440124-96-9 |
1234147-10MG |
10MG |
|
Efavirenz Related Compound B |
| 440124-96-9 |
1234147-10MG |
10MG |
|
Efavirenz Related Compound B |
| 443-48-1 |
1442009-100MG |
100MG |
|
Metronidazole 甲硝唑 |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 446292-08-6 |
1604596-20MG |
20MG |
|
Rivaroxaban Related Compound G |
| 50-01-1 |
1302134-100MG |
100MG |
|
Guanidine Hydrochloride (100 mg) |
| 50890-83-0 |
1298140-15MG |
15MG |
|
Granisetron Related Compound D 1-甲基吲唑-3-羧酸 |
| 51022-70-9 |
1012633-200MG |
200MG |
|
Albuterol Sulfate (200 mg) Albuterol sulfate United States Pharmacopeia (USP) Reference Standard |
| 56-23-5 |
1601168-3X1.2ML |
3X1.2ML |
|
Residual Solvent Class 1 - Carbon Tetrachloride 四氯化碳 溶液 |
| 56038-13-2 |
1623626-400MG |
400MG |
|
Sucralose 三氯蔗糖 |
| 573691-09-5 |
1042689-25MG |
25MG |
|
Aripiprazole Related Compound F |
| 596-09-8 |
1182000-200MG |
200MG |
|
Diacetylfluorescein 荧光素二乙酸盐 |
| 596-09-8 |
1182000-200MG |
200MG |
|
Diacetylfluorescein 荧光素二乙酸盐 |
| 6055-19-2 |
1157002-500MG |
500MG |
|
Cyclophosphamide (500 mg) |
| 608-07-1 |
1380116-15MG |
15MG |
|
Melatonin Related Compound A O-甲氧基色胺 |
| 63-37-6 |
1162126-500MG |
500MG |
|
5′-Cytidylic acid 5′-胞苷酸 |
| 63-37-6 |
1162126-500MG |
500MG |
|
5′-Cytidylic acid 5′-胞苷酸 |
| 64211-06-9 |
1483447-20MG |
20MG |
|
Oxiconazole Related Compound B |
| 65872-41-5 |
1097680-20MG |
20MG |
|
Cefepime Related Compound D (20 mg) ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid) |
| 67-20-9 |
1464001-500MG |
500MG |
|
Nitrofurantoin 呋喃妥因 |
| 67-20-9 |
1464001-500MG |
500MG |
|
Nitrofurantoin 呋喃妥因 |
| 67-64-1 |
1006801-3AMP |
3AMP |
|
Acetone 丙酮 |
| 69712-56-7 |
1097975-500MG |
500MG |
|
Cefotetan (500 mg) |
| 69712-56-7 |
1097975-500MG |
500MG |
|
Cefotetan (500 mg) |
| 70359-46-5 |
1076400-250MG |
250MG |
|
Brimonidine tartrate 酒石酸溴莫尼定 |
| 7048-04-6 |
1161509-600MG |
600MG |
|
?-Cysteine hydrochloride ?-半胱氨酸 盐酸盐 |
| 70918-74-0 |
1225420-20MG |
20MG |
|
Doxazosin Related Compound A 多沙唑嗪相关化合物A |
| 70918-74-0 |
1225420-20MG |
20MG |
|
Doxazosin Related Compound A 多沙唑嗪相关化合物A |
| 7147-77-5 |
1163184-50MG |
50MG |
|
Dantrolene Related Compound C 5-(4-硝基苯)糠醛 |
| 73-32-5 |
1349502-200MG |
200MG |
|
?-Isoleucine L-异亮氨酸 |
| 73963-62-9 |
1134175-50MG |
50MG |
|
Cilostazol Related Compound B |
| 73963-72-1 |
1134153-200MG |
200MG |
|
Cilostazol |
| 7488-56-4 |
1611966-200MG |
200MG |
|
Selenium Sulfide |
| 75607-67-9 |
1272204-300MG |
300MG |
|
Fludarabine phosphate 氟达拉滨 |
| 75607-67-9 |
1272204-300MG |
300MG |
|
Fludarabine phosphate 氟达拉滨 |
| 7647-15-6 |
1613597-1G |
1G |
|
Sodium bromide 溴化钠 |
| 7647-15-6 |
1613597-1G |
1G |
|
Sodium bromide 溴化钠 |
| 7664-38-2 |
1535802-3X1.5ML |
3X1.5ML |
|
Phosphoric acid United States Pharmacopeia (USP) Reference Standard 磷酸 |
| 7681-11-0 |
1548280-1G |
1G |
|
Potassium iodide 碘化钾 |
| 7681-11-0 |
1548280-1G |
1G |
|
Potassium iodide 碘化钾 |
| 76824-35-6 |
1269200-125MG |
125MG |
|
Famotidine 法莫替丁 |
| 77-36-1 |
1130006-200MG |
200MG |
|
Chlorthalidone United States Pharmacopeia (USP) Reference Standard |
| 7757-82-6 |
1614807-1G |
1G |
|
Sodium sulfate anhydrous 无水硫酸钠 |
| 7757-82-6 |
1614807-1G |
1G |
|
Sodium sulfate anhydrous 无水硫酸钠 |
| 7758-11-4 |
1551128-500MG |
500MG |
|
Dibasic potassium phosphate 磷酸氢二钾 |
| 7758-11-4 |
1551128-500MG |
500MG |
|
Dibasic potassium phosphate 磷酸氢二钾 |
| 7758-11-4 |
1551128-500MG |
500MG |
|
Dibasic potassium phosphate 磷酸氢二钾 |
| 7758-11-4 |
1551128-500MG |
500MG |
|
Dibasic potassium phosphate 磷酸氢二钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7758-11-4 |
1551128-5G |
5G |
|
Dibasic potassium phosphate United States Pharmacopeia (USP) Reference Standard 磷酸钾 |
| 7778-77-0 |
1551139-5G |
5G |
|
Monobasic potassium phosphate 磷酸二氢钾 |
| 7778-77-0 |
1551139-5G |
5G |
|
Monobasic potassium phosphate 磷酸二氢钾 |
| 81-81-2 |
1719000-200MG |
200MG |
|
Warfarin 华法林 |
| 82586-62-7 |
1445642-20MG |
20MG |
|
Moexipril Related Compound E (S)-(-)-6,7-二甲氧基-1,2,3,4-四氢异喹啉-3-羧酸 盐酸盐 |
| 82586-62-7 |
1445642-20MG |
20MG |
|
Moexipril Related Compound E (S)-(-)-6,7-二甲氧基-1,2,3,4-四氢异喹啉-3-羧酸 盐酸盐 |
| 82640-04-8 |
1598201-200MG |
200MG |
|
Raloxifene Hydrochloride (200 mg) |
| 83881-37-2 |
1102952-25MG |
25MG |
|
Cetirizine Related Compound C |
| 849206-43-5 |
1478378 |
20mg |
|
Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) 奥美沙坦酯组分A |
| 849206-43-5 |
1478378 |
20mg |
|
Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) 奥美沙坦酯组分A |
| 849206-43-5 |
1478378-20MG |
20MG |
|
Olmesartan medoxomil Related Compound A |
| 849206-43-5 |
1478378-20MG |
20MG |
|
Olmesartan medoxomil Related Compound A |
| 86357-09-7 |
1288317-15MG |
15MG |
|
Ganciclovir Related Compound A |
| 87500-74-1 |
1046409-10MG |
10MG |
|
Open Ring Aztreonam (10 mg) Open Ring Aztreonam United States Pharmacopeia (USP) Reference Standard |
| 87500-74-1 |
1046409-10MG |
10MG |
|
Open Ring Aztreonam (10 mg) Open Ring Aztreonam United States Pharmacopeia (USP) Reference Standard |
| 9002-92-0 |
1372402-500MG |
500MG |
|
Polyoxyl lauryl ether United States Pharmacopeia (USP) Reference Standard Polyoxyl lauryl ether United States Pharmacopeia (USP) Reference Standard |
| 9002-92-0 |
1372402-500MG |
500MG |
|
Polyoxyl lauryl ether United States Pharmacopeia (USP) Reference Standard Polyoxyl lauryl ether United States Pharmacopeia (USP) Reference Standard |
| 9002-92-0 |
1372468-0.5G |
0.5G |
|
Polyoxyl 23 lauryl ether 聚乙二醇23十二醚 |
| 9002-92-0 |
1372468-0.5G |
0.5G |
|
Polyoxyl 23 lauryl ether 聚乙二醇23十二醚 |
| 9002-92-0 |
1372468-0.5MG |
0.5MG |
|
Polyoxyl 23 Lauryl Ether (0.5 g) Polyoxyl 23 lauryl ether United States Pharmacopeia (USP) Reference Standard |
| 9002-92-0 |
1372468-0.5MG |
0.5MG |
|
Polyoxyl 23 Lauryl Ether (0.5 g) Polyoxyl 23 lauryl ether United States Pharmacopeia (USP) Reference Standard |
| 90237-03-9 |
1269298-25MG |
25MG |
|
Famotidine sulfoxide United States Pharmacopeia (USP) Reference Standard |
| 92-55-7 |
1465503-100MG |
100MG |
|
Nitrofurfural diacetate 5-硝基-2-呋喃甲醛二乙酸酯 |
| 92-55-7 |
1465503-100MG |
100MG |
|
Nitrofurfural diacetate 5-硝基-2-呋喃甲醛二乙酸酯 |
| 92-84-2 |
1525707-500MG |
500MG |
|
Phenothiazine 吩噻嗪 |
| 95-25-0 |
1130505-350MG |
350MG |
|
Chlorzoxazone |
| 95153-31-4 |
1510903-10MG |
10MG |
|
Perindopril Related Compound B |
| 95153-31-4 |
1510903-10MG |
10MG |
|
Perindopril Related Compound B |
| 97963-62-7 |
1494920-20MG |
20MG |
|
Pantoprazole Related Compound C 5-(二氟甲氧基)-2-巯基-1H-苯并咪唑 |
| 97963-62-7 |
1494920-20MG |
20MG |
|
Pantoprazole Related Compound C 5-(二氟甲氧基)-2-巯基-1H-苯并咪唑 |
| 98-79-3 |
1589029-30MG |
30MG |
|
Pyroglutamic Acid ?-焦谷氨酸 |
| 98-79-3 |
1589029-30MG |
30MG |
|
Pyroglutamic Acid ?-焦谷氨酸 |
粤ICP备20060492号-2
